KBC Group’s Transmedics TMDX Stock Holding History

KBC Group’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.3M	Sell	15,526 -444	-3%	-$36.5K	﹤0.01%	708
2026 Q2	$1.06M	Buy	15,970 +15,000	+1,546%	+$1.27M	﹤0.01%	733
2026 Q1	$96K	Hold	970	–	–	﹤0.01%	1342
2025 Q4	$118K	Hold	970	–	–	﹤0.01%	1187
2025 Q3	$109K	Hold	970	–	–	﹤0.01%	1210
2025 Q2	$130K	Sell	970 -589	-38%	-$64.7K	﹤0.01%	1060
2025 Q1	$105K	Hold	1,559	–	–	﹤0.01%	1456
2024 Q4	$97K	Buy	1,559 +638	+69%	+$59.4K	﹤0.01%	1583
2024 Q3	$145K	Hold	921	–	–	﹤0.01%	1070
2024 Q2	$139K	Buy	921 +154	+20%	+$18.5K	﹤0.01%	1008
2024 Q1	$57K	Hold	767	–	–	﹤0.01%	1476
2023 Q4	$61K	Hold	767	–	–	﹤0.01%	1383
2023 Q3	$42K	Buy	+767	New	+$55.2K	﹤0.01%	1591

Other funds holding TMDX

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $31.5B AUM 27.89% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $7.14B AUM 65.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return

KBC Group's TMDX Position: Q3 2026 in Review

KBC Group reduced its Transmedics (TMDX) stake by 2.8% in Q3 2026, selling an estimated $36.5K and leaving 15,526 shares worth $1.3M. The position accounts for ﹤0.01% of the portfolio, ranked #708.

KBC Group first reported a position in TMDX in Q3 2023 and has held it in 13 quarters since. 300 funds tracked by Wall St. Rank hold TMDX as of Q3 2026.

KBC Group held 15,526 shares of Transmedics worth $1.3M as of Q3 2026.
KBC Group sold 444 Transmedics shares in Q3 2026, an estimated $36.5K.
Transmedics made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #708 holding.
KBC Group first reported a position in Transmedics in Q3 2023 and has held it in 13 quarters since.
300 funds tracked by Wall St. Rank held Transmedics as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.